ODAPH
geneOn this page
Also known as FLJ23657AI2A4
Summary
ODAPH (odontogenesis associated phosphoprotein, HGNC:26300) is a protein-coding gene on chromosome 4q21.1, encoding Odontogenesis associated phosphoprotein (Q17RF5). May promote nucleation of hydroxyapatite.
Dental enamel forms the outer cap of teeth and is the hardest substance found in vertebrates. This gene is thought to encode an extracellular matrix acidic phosphoprotein that has a function in enamel mineralization during amelogenesis. Mutations in this gene are associated with recessive hypomineralized amelogenesis imperfecta.
Source: NCBI Gene 152816 — RefSeq curated summary.
At a glance
- Gene–disease (curated): amelogenesis imperfecta hypomaturation type 2A4 (Strong, GenCC) — +1 more curated relationship
- GWAS associations: 2
- Clinical variants (ClinVar): 24 total — 3 pathogenic, 4 likely-pathogenic
- Phenotypes (HPO): 4
- MANE Select transcript:
NM_178497
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26300 |
| Approved symbol | ODAPH |
| Name | odontogenesis associated phosphoprotein |
| Location | 4q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ23657, AI2A4 |
| Ensembl gene | ENSG00000174792 |
| Ensembl biotype | protein_coding |
| OMIM | 614829 |
| Entrez | 152816 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000311623, ENST00000435974, ENST00000511093, ENST00000514064, ENST00000616557
RefSeq mRNA: 3 — MANE Select: NM_178497
NM_001206981, NM_001257072, NM_178497
CCDS: CCDS3569, CCDS56334, CCDS75142
Canonical transcript exons
ENST00000311623 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000000344 | 75556066 | 75556149 |
| ENSE00001762032 | 75564114 | 75564817 |
Expression profiles
Bgee: expression breadth ubiquitous, 153 present calls, max score 77.92.
FANTOM5 (CAGE): breadth broad, TPM avg 3.0045 / max 2324.3356, expressed in 215 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 48301 | 3.0045 | 215 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.92 | gold quality |
| buccal mucosa cell | CL:0002336 | 69.50 | silver quality |
| placenta | UBERON:0001987 | 68.95 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 63.48 | gold quality |
| gastrocnemius | UBERON:0001388 | 62.27 | gold quality |
| spinal cord | UBERON:0002240 | 61.37 | gold quality |
| muscle of leg | UBERON:0001383 | 60.32 | gold quality |
| mucosa of stomach | UBERON:0001199 | 59.61 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 58.04 | gold quality |
| gingiva | UBERON:0001828 | 57.55 | gold quality |
| ileal mucosa | UBERON:0000331 | 57.47 | silver quality |
| tibialis anterior | UBERON:0001385 | 57.37 | silver quality |
| substantia nigra | UBERON:0002038 | 56.83 | gold quality |
| amygdala | UBERON:0001876 | 56.56 | gold quality |
| nucleus accumbens | UBERON:0001882 | 56.04 | gold quality |
| putamen | UBERON:0001874 | 55.93 | gold quality |
| midbrain | UBERON:0001891 | 54.87 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 54.82 | gold quality |
| right uterine tube | UBERON:0001302 | 54.74 | gold quality |
| tibial nerve | UBERON:0001323 | 54.54 | gold quality |
| cerebellar cortex | UBERON:0002129 | 54.52 | gold quality |
| hypothalamus | UBERON:0001898 | 54.48 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| right frontal lobe | UBERON:0002810 | 54.04 | gold quality |
| caudate nucleus | UBERON:0001873 | 54.01 | gold quality |
| gingival epithelium | UBERON:0001949 | 54.00 | silver quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 53.69 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 53.65 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.56 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
115 targeting ODAPH, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
Literature-anchored findings (GeneRIF, showing 1)
- Autozygosity mapping and clonal sequencing of an Omani family identified mutations in the uncharacterized gene, C4orf26, as a cause of recessive hypomineralized amelogenesis imperfecta (PMID:22901946)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Odaph | ENSMUSG00000096035 |
| rattus_norvegicus | Odaph | ENSRNOG00000079983 |
Protein
Protein identifiers
Odontogenesis associated phosphoprotein — Q17RF5 (reviewed: Q17RF5)
All UniProt accessions (3): Q17RF5, A0A087WV33, D6RFW7
UniProt curated annotations — full annotation on UniProt →
Function. May promote nucleation of hydroxyapatite.
Subcellular location. Secreted.
Tissue specificity. Highly expressed in placenta.
Disease relevance. Amelogenesis imperfecta, hypomaturation type, 2A4 (AI2A4) [MIM:614832] A defect of enamel formation. The disorder involves both primary and secondary dentitions. The teeth have a shiny agar jelly appearance and the enamel is softer than normal. Brown pigment is present in middle layers of enamel. The disease is caused by variants affecting the gene represented in this entry.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q17RF5-1 | 1 | yes |
| Q17RF5-2 | 2 |
RefSeq proteins (3): NP_001193910, NP_001244001, NP_848592* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031706 | ODAPH | Family |
Pfam: PF15848
UniProt features (6 total): sequence variant 2, signal peptide 1, chain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q17RF5-F1 | 61.64 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 88 (showing top):
RACCACAR_AML_Q6, GOBP_TOOTH_MINERALIZATION, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_ENAMEL_MINERALIZATION, OCT1_07, TGANTCA_AP1_C, GOBP_AMELOGENESIS, RYTTCCTG_ETS2_B, SENESE_HDAC1_TARGETS_UP, GOBP_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH, HAND1E47_01, GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS, COWLING_MYCN_TARGETS, chr4q21, GOBP_ODONTOGENESIS
GO Biological Process (2): positive regulation of biomineral tissue development (GO:0070169), positive regulation of enamel mineralization (GO:0070175)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| biomineral tissue development | 1 |
| positive regulation of developmental process | 1 |
| regulation of biomineral tissue development | 1 |
| enamel mineralization | 1 |
| positive regulation of tooth mineralization | 1 |
| regulation of enamel mineralization | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
250 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ODAPH | WDR72 | Q3MJ13 | 813 |
| ODAPH | SACK1H | Q6ZRV2 | 773 |
| ODAPH | ENAM | Q9NRM1 | 773 |
| ODAPH | MMP20 | O60882 | 728 |
| ODAPH | AMBN | Q9NP70 | 720 |
| ODAPH | AMTN | Q6UX39 | 720 |
| ODAPH | AMELX | Q99217 | 720 |
| ODAPH | SLC24A4 | Q8NFF2 | 696 |
| ODAPH | GPR68 | Q15743 | 683 |
| ODAPH | FAM20A | Q96MK3 | 665 |
| ODAPH | ODAM | A1E959 | 653 |
| ODAPH | KLK4 | Q9Y5K2 | 637 |
| ODAPH | ACP4 | Q9BZG2 | 620 |
| ODAPH | MMP25 | Q9NPA2 | 606 |
| ODAPH | LAMB3 | Q13751 | 602 |
IntAct
16 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ODAPH | MDFI | psi-mi:“MI:0915”(physical association) | 0.720 |
| ODAPH | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCN2 | ODAPH | psi-mi:“MI:0915”(physical association) | 0.560 |
| ODAPH | TCAF2 | psi-mi:“MI:0914”(association) | 0.530 |
| ODAPH | MDFI | psi-mi:“MI:0915”(physical association) | 0.000 |
| ODAPH | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ODAPH | LCN2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (75): C4orf26 (Two-hybrid), NUDT8 (Affinity Capture-MS), C9orf41 (Affinity Capture-MS), ANKRD50 (Affinity Capture-MS), JMJD4 (Affinity Capture-MS), SLC4A7 (Affinity Capture-MS), FBN1 (Affinity Capture-MS), FAM115C (Affinity Capture-MS), TRPC4AP (Affinity Capture-MS), NPHP3 (Affinity Capture-MS), GPC3 (Affinity Capture-MS), PMPCB (Affinity Capture-MS), PMPCA (Affinity Capture-MS), HAPLN3 (Affinity Capture-MS), TOP3A (Affinity Capture-MS)
ESM2 similar proteins: A0A0G2K6Z9, A0A1D0BN92, A0A411D538, A1YQ92, B3A0Q4, D5L5Q8, H2A0M0, K9N4Q4, O08546, O15946, O35979, O35985, O36359, P06796, P07498, P0DMD3, P0DMD4, P11841, P13432, P15450, P18897, P34468, P54684, P55796, P79139, P81058, P81059, P83055, P83474, P86735, Q01493, Q09283, Q17RF5, Q28441, Q28451, Q28794, Q29135, Q29137, Q61900, Q7T6X1
Diamond homologs: A0A0G2K6Z9, Q17RF5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 3 |
| Likely pathogenic | 4 |
| Uncertain significance | 1 |
| Likely benign | 5 |
| Benign | 7 |
Top pathogenic / likely-pathogenic (7)
| Variant ID | HGVS | Classification |
|---|---|---|
| 37216 | NM_178497.5(ODAPH):c.229C>T (p.Arg77Ter) | Pathogenic |
| 37217 | NM_178497.5(ODAPH):c.129C>A (p.Cys43Ter) | Pathogenic |
| 37218 | NM_178497.5(ODAPH):c.68-2A>T | Pathogenic |
| 3357780 | NM_178497.5(ODAPH):c.68-2A>G | Likely pathogenic |
| 37219 | NM_178497.3(C4orf26):c.318G>A | Likely pathogenic |
| 37220 | NM_178497.5(ODAPH):c.51_56delinsATGCTGGTTACTGGTA (p.Val18fs) | Likely pathogenic |
| 4813733 | NM_178497.5(ODAPH):c.225dup (p.Pro76fs) | Likely pathogenic |
SpliceAI
273 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:75564109:CACAG:C | acceptor_loss | 0.9900 |
| 4:75564111:CAGGA:C | acceptor_loss | 0.9900 |
| 4:75564112:A:AG | acceptor_gain | 0.9900 |
| 4:75564112:AGG:A | acceptor_loss | 0.9900 |
| 4:75564113:G:A | acceptor_loss | 0.9900 |
| 4:75564113:G:GG | acceptor_gain | 0.9900 |
| 4:75556148:AG:A | donor_loss | 0.9700 |
| 4:75556149:GG:G | donor_loss | 0.9700 |
| 4:75556150:GTAAG:G | donor_loss | 0.9700 |
| 4:75556146:GAAG:G | donor_gain | 0.9600 |
| 4:75564112:AG:A | acceptor_gain | 0.9500 |
| 4:75564113:GG:G | acceptor_gain | 0.9500 |
| 4:75556133:G:GA | donor_gain | 0.9200 |
| 4:75564113:GGA:G | acceptor_gain | 0.9200 |
| 4:75558106:GCTCT:G | donor_gain | 0.9000 |
| 4:75564110:A:AG | acceptor_gain | 0.9000 |
| 4:75556117:T:A | donor_gain | 0.8700 |
| 4:75556138:C:G | donor_gain | 0.8700 |
| 4:75564113:GGAC:G | acceptor_gain | 0.8700 |
| 4:75564113:GGACA:G | acceptor_gain | 0.8700 |
| 4:75558150:T:TA | donor_gain | 0.8600 |
| 4:75558151:A:AA | donor_gain | 0.8600 |
| 4:75564112:A:C | acceptor_gain | 0.8600 |
| 4:75564219:TCAC:T | donor_gain | 0.8600 |
| 4:75558155:ACCT:A | donor_gain | 0.8500 |
| 4:75563208:A:AG | acceptor_gain | 0.8500 |
| 4:75563209:G:GG | acceptor_gain | 0.8500 |
| 4:75563209:GTA:G | acceptor_gain | 0.8500 |
| 4:75564111:CA:C | acceptor_gain | 0.8500 |
| 4:75556150:G:GG | donor_gain | 0.8400 |
AlphaMissense
847 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:75564419:A:C | S125R | 0.911 |
| 4:75564421:C:A | S125R | 0.911 |
| 4:75564421:C:G | S125R | 0.911 |
| 4:75564182:T:C | F46L | 0.898 |
| 4:75564184:T:A | F46L | 0.898 |
| 4:75564184:T:G | F46L | 0.898 |
| 4:75564434:A:C | S130R | 0.881 |
| 4:75564436:C:A | S130R | 0.881 |
| 4:75564436:C:G | S130R | 0.881 |
| 4:75564429:A:T | E128V | 0.841 |
| 4:75564314:T:C | F90L | 0.813 |
| 4:75564316:C:A | F90L | 0.813 |
| 4:75564316:C:G | F90L | 0.813 |
| 4:75564426:C:T | S127F | 0.808 |
| 4:75564175:C:G | C43W | 0.799 |
| 4:75564183:T:G | F46C | 0.798 |
| 4:75564426:C:A | S127Y | 0.797 |
| 4:75556122:T:C | C14R | 0.796 |
| 4:75564183:T:C | F46S | 0.784 |
| 4:75564180:T:C | I45T | 0.779 |
| 4:75556125:T:A | W15R | 0.777 |
| 4:75556125:T:C | W15R | 0.777 |
| 4:75564173:T:C | C43R | 0.765 |
| 4:75564299:T:C | F85L | 0.760 |
| 4:75564301:T:A | F85L | 0.760 |
| 4:75564301:T:G | F85L | 0.760 |
| 4:75564347:T:C | F101L | 0.753 |
| 4:75564349:C:A | F101L | 0.753 |
| 4:75564349:C:G | F101L | 0.753 |
| 4:75564341:T:C | F99L | 0.750 |
dbSNP variants (sampled 300 via entrez): RS1000094572 (4:75564826 C>T), RS1000288026 (4:75561034 G>A), RS1000490226 (4:75555196 C>T), RS1000519307 (4:75564375 A>G), RS1000530658 (4:75561922 T>A,C,G), RS1000536462 (4:75566340 T>A), RS1000688982 (4:75556358 C>G), RS1000731169 (4:75558840 T>C), RS1000794163 (4:75560166 G>A), RS1000998765 (4:75556025 C>A), RS1001320637 (4:75561084 C>A,T), RS1001410377 (4:75561178 C>G,T), RS1001644152 (4:75565425 T>A,C), RS1001654736 (4:75559199 T>C), RS1001662052 (4:75555608 G>A,C,T)
Disease associations
OMIM: gene MIM:614829 | disease phenotypes: MIM:614832
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| amelogenesis imperfecta hypomaturation type 2A4 | Strong | Autosomal recessive |
| amelogenesis imperfecta type 2 | Supportive | Autosomal recessive |
Mondo (2): amelogenesis imperfecta hypomaturation type 2A4 (MONDO:0013906), amelogenesis imperfecta type 2 (MONDO:0015048)
Orphanet (1): Amelogenesis imperfecta (Orphanet:88661)
HPO phenotypes
4 total (4 of 4 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000705 | Amelogenesis imperfecta |
| HP:0006285 | Enamel hypomineralization |
| HP:0006297 | Enamel hypoplasia |
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001546_4 | Parkinson’s disease (motor and cognition) | 5.000000e-06 |
| GCST003160_4 | Subjective response to lithium treatment in bipolar disorder | 7.000000e-07 |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C536606 | Amelogenesis Imperfecta hypomaturation type (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Estradiol | increases expression, decreases expression, affects cotreatment | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Diethylhexyl Phthalate | increases expression | 1 |
| Diuron | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Triclosan | increases expression | 1 |
| Zearalenone | decreases expression | 1 |
| beta-Naphthoflavone | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: amelogenesis imperfecta hypomaturation type 2A4, amelogenesis imperfecta type 2
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): amelogenesis imperfecta hypomaturation type 2A4, amelogenesis imperfecta type 2